Johnson & Johnson operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Johnson & Johnson with three other
major healthcare and pharmaceutical companies:
Bristol-Myers Squibb Company
(2018
sales of $22.56 billion
of which 100%
was BioPharmaceuticals),
Baxter International Inc.
($11.13 billion
of which 54%
was Americas), and
Novartis AG
which is
based in Switzerland
(51.94 billion Swiss Francs [US$52.20 billion]
of which 66%
was Innovative Medicines).
Sales Analysis.
During the year ended December of 2018, sales at
Johnson & Johnson were $81.58 billion.
This
is
an
increase of 6.7%
versus 2017, when the company's sales were $76.45 billion.
This was the third consecutive year of growth at Johnson & Johnson.
Sales of Pharmaceutical saw an increase
of
12.4% in 2018, from
$36.26 billion to $40.73 billion.